Todd C. Davis - 04 Dec 2025 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Executive Officer, Director
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Todd C. Davis
Issuer symbol
LGND
Transactions as of
04 Dec 2025
Net transactions value
$0
Form type
4
Filing time
08 Dec 2025, 19:37:58 UTC
Previous filing
07 Jul 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Davis Todd C Chief Executive Officer, Director 555 HERITAGE DRIVE, SUITE 200, JUPITER By: /s/ Andrew Reardon, Attorney-in-Fact For: Todd C. Davis 08 Dec 2025 0001392029

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Gift $0 -130 -0.08% $0.000000 161,337 04 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a bona fide gift of shares to a charitable entity.